Delivery Order SPE2DB22D3016-SPE2DB23FBSV5
- Not listed
- This federal contract award, valued at $9,072.25, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lotrel 10-20 mg capsules to support military healthcare programs. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. The company holds a significant Indefinite Delivery Contract (IDC) with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $7,929.42 firm fixed-price delivery order is for the supply of LOTREL 10-20 MG CAPSULE 100S, a pharmaceutical product, to support military and government healthcare programs. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
- This federal contract award, valued at $9,262.99, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LOTREL 10-20 MG CAPSULE 100S, a cardiovascular medication, with a completion date of September 19, 2023. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award, valued at $24,980.73, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order under the DLA's Indefinite Delivery Contract (IDC) with Amerisourcebergen, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to supply a comprehensive range of pharmaceutical products and medical supplies, including...
- This federal contract award, valued at $3,420.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of LOTREL 10-20 MG CAPSULE 100S, a pharmaceutical product, to fulfill the medical supply needs of the DLA Troop Support Medical program. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA, valued at up to $999,999,999.00 and running...
- This federal contract award, valued at $33,589.39, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of LOTREL 10-20 MG CAPSULE 100S, a cardiovascular medication. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This federal contract award is a delivery order valued at $11,195.19 made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract covers the delivery of Lotrel 10-20 mg capsules, a cardiovascular medication, through February 2024. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00...
- This federal contract award, valued at $2,283.51, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LOTREL 10-20 MG CAPSULE 100S, a cardiovascular medication. This contract is a delivery order that is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of LOTREL 10-20 MG CAPSULES 100S. The contract has a firm fixed price of $13,284.40 and an ultimate completion date of September 21, 2023. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at up to...
- This federal contract award, valued at $133,534.07, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LOTREL 10-20 MG CAPSULE 100S, a cardiovascular medication, to support military and veteran healthcare programs. Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB23FBSV5Delivery Order
This federal contract award, valued at $11,247.29, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of LOTREL 10-20 MG CAPSULE 100S, a pharmaceutical product. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This contract award is not designated as a set-aside. Amerisourcebergen Drug Corp also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.2k | 9/20/23 |